These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8112029)

  • 1. Effect of protein on ramoplanin broth microdilution minimum inhibitory concentrations.
    Scotti R; Dulworth JK; Kenny MT; Goldstein BP
    Diagn Microbiol Infect Dis; 1993 Oct; 17(3):209-11. PubMed ID: 8112029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of ramoplanin MICs.
    Kenny MT; Brackman MA
    J Clin Microbiol; 1994 May; 32(5):1364-5. PubMed ID: 8051270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ramoplanin susceptibility testing criteria.
    Barry AL; Pfaller MA; Fuchs PC
    J Clin Microbiol; 1993 Jul; 31(7):1932-5. PubMed ID: 8349779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different broth dilution procedures generate different apparent MICs for ramoplanin.
    Bartoloni A; Mantella A; Goldstein BP; Denaro M; Paradisi F
    J Antimicrob Chemother; 1994 Jun; 33(6):1252-3. PubMed ID: 7928821
    [No Abstract]   [Full Text] [Related]  

  • 6. Bactericidal activity of ramoplanin against antibiotic-resistant enterococci.
    Johnson CC; Taylor S; Pitsakis P; May P; Levison ME
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2342-5. PubMed ID: 1444316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ramoplanin on staphylococci.
    Francis J; Webster H; Newsom SW
    Drugs Exp Clin Res; 1990; 16(9):457-60. PubMed ID: 2100247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
    Kavanagh A; Ramu S; Gong Y; Cooper MA; Blaskovich MAT
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
    Collins LA; Eliopoulos GM; Wennersten CB; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1364-6. PubMed ID: 8328787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(3):279-82. PubMed ID: 2507218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramoplanin versus methicillin-resistant Staphylococcus aureus: in vitro experience.
    Brumfitt W; Maple PA; Hamilton-Miller JM
    Drugs Exp Clin Res; 1990; 16(8):377-83. PubMed ID: 2097143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods.
    Hastey CJ; Dale SE; Nary J; Citron D; Law JH; Roe-Carpenter DE; Chesnel L
    Anaerobe; 2017 Apr; 44():73-77. PubMed ID: 28188880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
    Ristow TA; Noskin GA; Warren JR; Peterson LR
    Microb Drug Resist; 1995; 1(4):335-9. PubMed ID: 9158806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
    Freeman C; Robinson A; Cooper B; Mazens-Sullivan M; Quintiliani R; Nightingale C
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):47-50. PubMed ID: 7789096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.
    Klare I; Konstabel C; Müller-Bertling S; Reissbrodt R; Huys G; Vancanneyt M; Swings J; Goossens H; Witte W
    Appl Environ Microbiol; 2005 Dec; 71(12):8982-6. PubMed ID: 16332905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice.
    Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2144-8. PubMed ID: 15155213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of Clostridium difficile strains to teicoplanin and ramoplanin].
    Dworczyński A; Martirosian G; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1993; 45(4):483-6. PubMed ID: 8189828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically.
    Koeth LM; DiFranco-Fisher JM; McCurdy S
    J Vis Exp; 2015 Sep; (103):. PubMed ID: 26381422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary biological characterization of new semisynthetic derivatives of ramoplanin.
    Ciabatti R; Maffioli SI; Panzone G; Canavesi A; Michelucci E; Tiseni PS; Marzorati E; Checchia A; Giannone M; Jabes D; Romano G; Brunati C; Candiani G; Castiglione F
    J Med Chem; 2007 Jun; 50(13):3077-85. PubMed ID: 17542573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.